Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Focus Green: Fluorescence-guided resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine Green
2023-504615-33-00Phase 2Completed
- Sponsor
- Leiden University Medical Center
- Start
- Aug 2023
- Modality
- Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sgm-101 in colorectal cancer (CRC), sponsored by Leiden University Medical Center. Started Aug 2023; status: completed.
02
Drugs
sgm-101
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2023-504615-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504615-33-00.